GLP-1 inhibitors may curb heart failure risk in diabetes

03/26/2013 | MedPage Today (free registration)

Diabetes patients taking GLP-1 inhibitors were 41% less likely to develop heart failure compared with those on other glucose-lowering medications, a study indicated. Researchers also found the patients on GLP-1 inhibitors had a 44% lower risk of all-cause hospitalization and an 80% lower risk of all-cause mortality than those not on such medications. The findings were presented at the American College of Cardiology meeting.

View Full Article in:

MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations